rdkriplani

Natco Pharma - Bottoming Out

NSE:NATCOPHARM   NATCO PHARMA LTD
Potentially the stock has bottomed out..the management has guided for big earnings going ahead and actively looking for an acquisition based off those earnings.
Technically the stock has been consolidating in the 625-650 range and now there is a double divergence on the RSI as well. The stock is also as close to a channel bottom as possible

Long at current prices with stploss below 600.

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.